Switzerland· 54553001
Sotalol-Mepha 80, Tabletten
A sotalol product, registered in Switzerland by Mepha Pharma AG and dispensed under Swissmedic category B. The same ATC class is registered in 19 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Sotalol is registered in 19 of 19 countries.
Countries holding a registration under ATC C07AA07 (sotalol), each read from that country’s own register.
- This record: Switzerland
- 11 of them publish a price we can compare per daily dose
Sotalol · ATC C07AA07
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of sotalol costs, country by country.
Normalised to the WHO defined daily dose (0.16 g), the median price runs from $0.14 in United States to $0.61 in Switzerland — a ×4.3 gap.
- Switzerland: $0.61 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Sotalol · price per daily dose (0.16 g)
USD · FX 28 Sept 2026
- CH Switzerland$0.61
- ES Spain$0.24
- IT Italy$0.19
- FR France$0.17
- US United States$0.14 (acquisition cost)
The record
At a glance
- Manufacturer
- Mepha Pharma AG
- Country
- Switzerland (CH)
- ATC code
- C07AA07
- ATC class
- Sotalol
- Defined daily dose
- 0.16 g, O
- Swissmedic category
- B
- Reimbursed
- No
- Last checked
- June 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
433 interactions on record for sotalol.
Graded by severity as the source publishes them — 147 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sotalol · interactions on record
433 records
- 147 severe
- 149 moderate
- 18 minor
- 67 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
52 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under C07AA07
Sotalol, as other registers publish it.
- CanadaAPO-SOTALOLAPOTEX INC
- CanadaAPO-SOTALOLAPOTEX INC
- United KingdomBeta-Cardone 200mg tabletsAdvanz Pharma
- United KingdomBeta-Cardone 40mg tabletsFocus Pharmaceuticals Ltd
- United KingdomBeta-Cardone 80mg tabletsFocus Pharmaceuticals Ltd
- United StatesBETAPACELegacy Pharma USA, Inc.
- United StatesBETAPACELegacy Pharma USA, Inc.
- United StatesBETAPACELegacy Pharma USA, Inc.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dca7686f-96b9-4104-8038-d5850934f60d GET /v1/drugs/dca7686f-96b9-4104-8038-d5850934f60d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Synthetika"
}See everything about sotalol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.